Other articles of interest

Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

Pablo García-Pavía, José Manuel García-Pinilla, Ainara Lozano-Bahamonde, Sergi Yun, Antonio García-Quintana, Juan José Gavira-Gómez, Miguel Ángel Aibar-Arregui, Gonzalo Barge-Caballero, Julio Núñez Villota, Laura Bernal, Patricia Tarilonte,

Rev Esp Cardiol. 2025;78:301-10
NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification?

Fabian Tran, Francisco Javier Ruperti-Repilado, Philip Haaf, Pedro Lopez-Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Juerg Schwitter, Kerstin Wustmann, Michael Freese, Christian Mueller, Daniel Tobler,

Rev Esp Cardiol. 2025;78:107-16
Outcomes of patients with heart failure followed in units accredited by the SEC-Excelente-IC quality program according to the type of unit

María Anguita Gámez, Juan L. Bonilla Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Javier Muñiz García, Nieves Romero Rodríguez, Francisco J. Elola Somoza, Ángel Cequier Fillat, Luis Rodríguez Padial, Manuel Anguita Sánchez,

Rev Esp Cardiol. 2025;78:12-21